title: Genetic susceptibility to refractive error: association of vasoactive intestinal peptide receptor 2 (VIPR2) with high myopia in Chinese.
abstract: Myopia is the most common ocular disease worldwide. We investigated the association of high myopia with the common single nucleotide polymorphisms (SNPs) of five candidate genes - early growth response 1 (EGR1), v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), jun oncogene (JUN), vasoactive intestinal peptide (VIP), and vasoactive intestinal peptide receptor 2 (VIPR2). We recruited 1200 unrelated Chinese subjects with 600 cases (spherical equivalent ≤-8.00 diopters) and 600 controls (spherical equivalent within ±1.00 diopter). A discovery sample set was formed from 300 cases and 300 controls, and a replication sample set from the remaining samples. Tag SNPs were genotyped for the discovery sample set, and the most significant haplotypes and their constituent SNPs were followed up with the replication sample set. The allele and haplotype frequencies in cases and controls were compared by logistic regression adjusted for sex and age to give P a values, and multiple comparisons were corrected by permutation test to give P aemp values. Odd ratios (OR) were calculated accordingly. In the discovery phase, EGR1, JUN and VIP did not show any significant association while FOS and VIPR2 demonstrated significant haplotype association with high myopia. In the replication phase, the haplotype association for VIPR2 was successfully replicated, but not FOS. In analysis combining both sample sets, the most significant association signals of VIPR2 were the single marker rs2071625 (P a = 0.0008, P aemp = 0.0046 and OR = 0.75) and the 4-SNP haplotype window rs2071623-rs2071625-rs2730220-rs885863 (omnibus test, P a = 9.10e-10 and P aemp = 0.0001) with one protective haplotype (GGGG: P aemp = 0.0002 and OR = 0.52) and one high-risk haplotype (GAGA: P aemp = 0.0027 and OR = 4.68). This 4-SNP haplotype window was the most significant in all sample sets examined. This is the first study to suggest a role of VIPR2 in the genetic susceptibility to high myopia. EGR1, JUN, FOS and VIP are unlikely to be important in predisposing humans to high myopia.
authors: Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong SAR, China.
authors: Wai Chi
authors: WC
authors: Yiu
authors: Maurice K H
authors: MK
authors: Yap
authors: Wai Yan
authors: WY
authors: Fung
authors: Po Wah
authors: PW
authors: Ng
authors: Shea Ping
authors: SP
authors: Yip
mesh_terms: D000328:Adult; D044466:Asian People / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D051239:Receptors, Vasoactive Intestinal Peptide, Type II / Q000235:genetics*
chemical_list: D051239:Receptors, Vasoactive Intestinal Peptide, Type II
references: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4681-6
references: 16537371
references: Cell. 2002 May 17;109(4):497-508
references: 12086606
references: Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Aug;30(4):456-9
references: 16190398
references: Invest Ophthalmol Vis Sci. 2002 Jan;43(1):246-52
references: 11773038
references: Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3893-900
references: 21421877
references: PLoS Genet. 2012;8(6):e1002753
references: 22685421
references: Ophthalmology. 2009 Oct;116(10):1920-7
references: 19616852
references: Arch Ophthalmol. 2012 Feb;130(2):209-16
references: 22332214
references: Ophthalmology. 2011 Feb;118(2):368-75
references: 21095009
references: Mol Vis. 2008 Jul 15;14:1309-12
references: 18636116
references: Clin Exp Optom. 2008 Jan;91(1):4-22
references: 18045248
references: Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Aug;33(8):669-75
references: 18772504
references: Nat Genet. 2010 Oct;42(10):897-901
references: 20835239
references: PLoS One. 2011 May 12;6(5):e19587
references: 21589860
references: Biochim Biophys Acta. 1992 Nov 15;1171(1):41-55
references: 1420363
references: Exp Eye Res. 2006 Feb;82(2):185-200
references: 16202407
references: Surv Ophthalmol. 1999 Oct;44 Suppl 1:S109-115
references: 10548123
references: J Med Genet. 2002 Feb;39(2):118-24
references: 11836361
references: J Neurosci. 2004 Apr 7;24(14):3522-6
references: 15071099
references: Mol Vis. 2005 Apr 28;11:309-20
references: 15889015
references: Ophthalmic Physiol Opt. 2005 Sep;25(5):381-91
references: 16101943
references: Science. 1987 Jul 3;237(4810):73-7
references: 3603011
references: Br J Ophthalmol. 2010 Aug;94(8):1012-6
references: 20472747
references: Eur J Hum Genet. 2009 Jun;17(6):785-92
references: 19092774
references: Nat Genet. 2008 Jun;40(6):695-701
references: 18509313
references: N Engl J Med. 1985 Jun 20;312(25):1609-15
references: 4000200
references: Am J Hum Genet. 1998 Nov;63(5):1419-24
references: 9792869
references: Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4989-95
references: 20484597
references: Am J Hum Genet. 2005 May;76(5):887-93
references: 15789306
references: Bioinformatics. 2005 Jan 15;21(2):263-5
references: 15297300
references: Prog Retin Eye Res. 2003 May;22(3):307-38
references: 12852489
references: New Biol. 1991 Dec;3(12):1206-19
references: 1667479
references: Clin Genet. 2011 Apr;79(4):301-20
references: 21155761
references: Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11575-80
references: 11027354
references: Vis Neurosci. 2005 May-Jun;22(3):251-61
references: 16079001
references: Matrix Biol. 1995 Dec;14(9):715-25
references: 8785586
references: J Neurosci Methods. 1989 Sep;29(3):261-5
references: 2507830
references: Exp Eye Res. 2013 Sep;114:25-34
references: 23298452
references: Nat Genet. 2010 Oct;42(10):902-5
references: 20835236
references: Am J Hum Genet. 2007 Sep;81(3):559-75
references: 17701901
references: Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3116-27
references: 19324860
references: Ophthalmic Physiol Opt. 2012 Jan;32(1):3-16
references: 22150586
references: Arch Ophthalmol. 2001 Nov;119(11):1625-8
references: 11709012
references: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4080-6
references: 19387081
references: Arch Ophthalmol. 2009 Apr;127(4):541-8
references: 19365037
references: Am J Hum Genet. 1998 Jul;63(1):109-19
references: 9634508
references: Invest Ophthalmol Vis Sci. 2007 Jan;48(1):11-7
references: 17197510
references: Invest Ophthalmol Vis Sci. 2001 May;42(6):1312-8
references: 11328745
references: Nat Neurosci. 1999 Aug;2(8):706-12
references: 10412059